Sartorius Stock

Sartorius Equity

The The Equity of Sartorius (SRT.DE) as of Aug 7, 2026 is 2.71 B EUR. In the previous year, The Equity was 2.76 B EUR — a change of -2.10% (lower).

Equity

2.71 BEUR

YoY

-2.10%

Last updated:

In 2026, Sartorius's equity was 2.71 B EUR, a -2.10% increase from the 2.76 B EUR equity in the previous year.

Access this data via the Eulerpool API

Sartorius Stock analysis

What does Sartorius do? Sartorius AG is a globally operating company specializing in the development and manufacturing of laboratory equipment and process technologies. It was founded in 1870 by industrialist and entrepreneur Florenz Sartorius in Göttingen, Germany. The company initially focused on the sale of scales, weights, and measuring instruments but has since expanded and diversified its product line. Today, Sartorius AG is a world leader in the bioprocessing and laboratory equipment sectors and is known for its innovative products and procedures. The company's business model revolves around the development of high-tech products for applications in biotechnology, pharmaceuticals, and the food industry. It operates in two main business segments: Bioprocess Solutions and Lab Products & Services. The Bioprocess Solutions segment provides solutions and services for biopharmaceutical production, including filtration, fermentation, fluid management, and cell cultures. The products in this segment are typically disposable consumables used in the production of biopharmaceutical agents. The Lab Products & Services segment offers a wide range of laboratory equipment, from scales and microbiology equipment to ultrafiltration devices. These instruments are used by researchers and scientists in academic, industrial, and pharmaceutical laboratories worldwide. Furthermore, an important part of Sartorius' portfolio includes bioreactors and fermenters. These specialized devices are used for cultivating cells and microorganisms and are particularly important in biotechnology and vaccine production. Sartorius has established itself as a leader in this field through its innovative and high-performance products. In addition to the pharmaceutical, biotechnology, and laboratory sectors, Sartorius is also active in environmental technology. The company provides products and services for water analysis and purification, which are in demand in industries such as pharmaceuticals, food production, and environmental analysis due to their precise and reliable results. Sartorius demonstrates its innovation through the use of technologies such as machine learning and artificial intelligence. For example, the company offers the "Ambr" solution for fast and reliable modeling of production scenarios for biopharmaceutical agents. Machine learning techniques are employed to generate more data and make better decisions. Overall, Sartorius AG is a global company with a wide range of products and services for the biotechnology, pharmaceutical, chemical, and food industries. The company's innovation is evident in its continuous advancement of procedures, technologies, and products. With a strong market position and clear strategic direction, Sartorius will continue to be an important player in the industry and support the work of researchers and scientists worldwide with its high-performance products. Sartorius is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Sartorius's Equity

Sartorius's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Sartorius's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Sartorius's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Sartorius's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Sartorius’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Sartorius stock

The Equity of Sartorius is 2.71 B EUR in 2026.

The Equity of Sartorius changed from 2.76 B EUR to 2.71 B EUR, representing a -2.10% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity Sartorius since 2006 – with annual values, charts, and detailed analysis.

The Equity's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Sartorius historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Sartorius

All Key Metrics — Sartorius